Expression profiling of GIST: CD133 is associated with KIT exon 11 mutations, gastric location and poor prognosis
出版年份 2010 全文链接
标题
Expression profiling of GIST: CD133 is associated with KIT exon 11 mutations, gastric location and poor prognosis
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF CANCER
Volume 129, Issue 5, Pages 1149-1161
出版商
Wiley
发表日期
2010-11-10
DOI
10.1002/ijc.25755
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Targeted therapies of gastrointestinal stromal tumors (GIST)—The next frontiers
- (2010) Stefan Duensing et al. BIOCHEMICAL PHARMACOLOGY
- Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factor-β
- (2010) Hanning You et al. HEPATOLOGY
- CD133 expression predicts for non-response to chemotherapy in colorectal cancer
- (2010) Chee W Ong et al. MODERN PATHOLOGY
- Sunitinib
- (2009) Georgios S. Papaetis et al. BIODRUGS
- mTOR Signal and Hypoxia-Inducible Factor-1 Regulate CD133 Expression in Cancer Cells
- (2009) K. Matsumoto et al. CANCER RESEARCH
- Resistance to Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors
- (2009) A. W. Gramza et al. CLINICAL CANCER RESEARCH
- Cancer stem cells: a model in the making
- (2009) Lauren L Campbell Marotta et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Treatment of gastrointestinal stromal tumours: imatinib, sunitinib – and then?
- (2009) Bengt Nilsson et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Molecular Pathobiology of Gastrointestinal Stromal Sarcomas
- (2008) Christopher L. Corless et al. Annual Review of Pathology-Mechanisms of Disease
- Skp2 expression is associated with high risk and elevated Ki67 expression in gastrointestinal stromal tumours
- (2008) Dolores Di Vizio et al. BMC CANCER
- Abnormal DNA Methylation of CD133 in Colorectal and Glioblastoma Tumors
- (2008) J. M. Yi et al. CANCER RESEARCH
- Activity of Dasatinib, a Dual SRC/ABL Kinase Inhibitor, and IPI-504, a Heat Shock Protein 90 Inhibitor, against Gastrointestinal Stromal Tumor-Associated PDGFRAD842V Mutation
- (2008) B. Dewaele et al. CLINICAL CANCER RESEARCH
- Pfetin as a Prognostic Biomarker of Gastrointestinal Stromal Tumors Revealed by Proteomics
- (2008) Y. Suehara et al. CLINICAL CANCER RESEARCH
- Stem Cell Marker CD133 Affects Clinical Outcome in Glioma Patients
- (2008) F. Zeppernick et al. CLINICAL CANCER RESEARCH
- Distinct Gene Expression–Defined Classes of Gastrointestinal Stromal Tumor
- (2008) Umio Yamaguchi et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate At Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing the Kit Receptor Tyrosine Kinase: S0033
- (2008) Charles D. Blanke et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinicopathologic profile of gastrointestinal stromal tumors (GISTs) with primary KIT exon 13 or exon 17 mutations: a multicenter study on 54 cases
- (2008) Jerzy Lasota et al. MODERN PATHOLOGY
- Protein kinase C-θ regulates KIT expression and proliferation in gastrointestinal stromal tumors
- (2008) W-b Ou et al. ONCOGENE
- Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors
- (2008) C. Tarn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Stem Cell-Associated Antigen CD133 (Prominin-1) Is a Molecular Therapeutic Target for Metastatic Melanoma
- (2008) Germana Rappa et al. STEM CELLS
- Nestin expression in different tumours and its relevance to malignant grade
- (2007) X H Yang et al. JOURNAL OF CLINICAL PATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More